Thrombophylaxis in Transurethral Surgery With Dalteparine
NCT ID: NCT00681785
Last Updated: 2008-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
250 participants
INTERVENTIONAL
2006-06-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®
NCT01046903
Treatment of Upper Extremity Deep-Vein Thrombosis
NCT00245856
Evaluation of the Relevance of Antithrombin Prescriptions at Strasbourg University Hospitals
NCT07276074
Thromboprophylaxis in Critically Ill Patients
NCT00437697
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
NCT00445328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
5000IE dalteparine
dalteparine (Fragmin)
transurethrals surgery with and without dalteparine
B
NaCL 0.9%
dalteparine (Fragmin)
transurethrals surgery with and without dalteparine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dalteparine (Fragmin)
transurethrals surgery with and without dalteparine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Urology, Kantonsspital Liestal
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas C Gasser, Prof
Role: STUDY_CHAIR
Department of Urology Liestal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urologische Universitätsklinik beider Basel
Liestal, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
269/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.